Pemetrexed Disodium: Clinical Trials

11 trials of Pemetrexed Disodium, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

11 terminated. 11 Phase 2, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 211Terminated 11
Phase 12Terminated 2

Follow Pemetrexed Disodium: new trials by email Literature Review of Pemetrexed Disodium trials Research Report on Pemetrexed Disodium

Trials (filtered) newest first · largest first

All 11 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Nivolumab Plus Cisplatin/Pemetrexed or Cisplatin/Gemcitabine as Induction in Resectable Non-Small Cell Lung Cancer
Nivolumab, Cisplatin, Pemetrexed Disodium - Non-Squamous Non-Small Cell Lung Carcinoma, Stage I Non-Small Cell Lung Cancer
Phase 2TerminatedSidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University142017-12-202026-02-20
Pemetrexed Disodium in Treating Patients With Previously Treated Metastatic Urothelial Cancer
Laboratory Biomarker Analysis, Pemetrexed Disodium - Metastatic Urothelial Carcinoma
Phase 2TerminatedM.D. Anderson Cancer Center72017-05-092021-05-20
S1300: Pemetrexed Disodium With or Without Crizotinib in Treating Patients With Stage IV Non-Small Cell Lung Cancer That Has Progressed After Crizotinib
crizotinib, pemetrexed disodium, laboratory biomarker analysis - Adenocarcinoma of the Lung, Large Cell Lung Cancer
Phase 2TerminatedSWOG Cancer Research Network12014-08-012020-02-20
Azacitidine and Entinostat Before Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer
Azacitidine, Docetaxel, Entinostat - Recurrent Non-Small Cell Lung Carcinoma, Stage IIIA Non-Small Cell Lung Cancer
Phase 2TerminatedNational Cancer Institute (NCI)172013-05-012018-07-27
Intensity-Modulated Radiation Therapy, Pemetrexed, and Erlotinib in Treating Patients With Recurrent or Second Primary Head and Neck Cancer
erlotinib hydrochloride, pemetrexed disodium, quality-of-life assessment - Head and Neck Cancer
Phase 1 / Phase 2TerminatedWake Forest University Health Sciences272008-03-012019-01-03
Celecoxib and Docetaxel or Pemetrexed in Treating Patients With Advanced Recurrent Non-Small Cell Lung Cancer
celecoxib, Docetaxel, pemetrexed disodium - Lung Cancer
Phase 2TerminatedVanderbilt-Ingram Cancer Center232007-10-012017-03-20
Abraxane and Alimta in Advanced Solid Tumors
Abraxane, Alimta - Breast Cancer, Lung Cancer
Phase 1 / Phase 2TerminatedUniversity of California, Davis492007-04-012018-01-10
Pemetrexed Disodium and Cisplatin Before or After Surgery in Treating Patients With Stage IB or Stage II Non-Small Cell Lung Cancer That Can be Removed by Surgery
cisplatin, pemetrexed disodium, adjuvant therapy - Lung Cancer
Phase 2TerminatedEuropean Organisation for Research and Treatment of Cancer - EORTC132006-08-012012-07-18
Pemetrexed Disodium, Gemcitabine, and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
bevacizumab, gemcitabine hydrochloride, pemetrexed disodium - Lung Cancer
Phase 2TerminatedBarbara Ann Karmanos Cancer Institute392006-05-012021-04-13
Pemetrexed Disodium in Treating Patients With Recurrent or Persistent Low-Risk Gestational Trophoblastic Tumor After a Molar Pregnancy
pemetrexed disodium - Gestational Trophoblastic Tumor
Phase 2TerminatedGynecologic Oncology Group552005-07-012018-04-12
Whole-Brain Radiation Therapy and Pemetrexed in Treating Patients With Brain Metastases From Non-Small Cell Lung Cancer
pemetrexed disodium, radiation therapy - Lung Cancer, Metastatic Cancer
Phase 2TerminatedUNC Lineberger Comprehensive Cancer Center102005-05-012017-06-23

Conditions studied

Carcinoma, Non-Small-Cell Lung (8)  ·  Lung Neoplasms (5)  ·  Adenocarcinoma of Lung (2)  ·  Adenocarcinoma, Bronchiolo-Alveolar (1)  ·  Brain Neoplasms (1)  ·  Breast Neoplasms (1)  ·  Breast Neoplasms, Male (1)  ·  Carcinoma, Transitional Cell (1)  ·  Gestational Trophoblastic Disease (1)  ·  Head and Neck Neoplasms (1)  ·  Neoplasm Metastasis (1)  ·  Squamous Cell Carcinoma of Head and Neck (1)

Sponsors

Barbara Ann Karmanos Cancer Institute (1)  ·  European Organisation for Research and Treatment of Cancer - EORTC (1)  ·  Gynecologic Oncology Group (1)  ·  M.D. Anderson Cancer Center (1)  ·  National Cancer Institute (NCI) (1)  ·  SWOG Cancer Research Network (1)  ·  Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University (1)  ·  UNC Lineberger Comprehensive Cancer Center (1)  ·  University of California, Davis (1)  ·  Vanderbilt-Ingram Cancer Center (1)  ·  Wake Forest University Health Sciences (1)

Countries

United States (10)  ·  Belgium (1)

Top investigators

Allan Covens, MD (1)  ·  Antoinette J. Wozniak, MD (1)  ·  David Camidge (1)  ·  David R. Gandara, MD (1)  ·  David S. Miller, MD (1)  ·  Jianjun Gao (1)  ·  Julie Brahmer (1)  ·  Kathryn M. Greven, MD (1)  ·  Leora Horn, MD (1)  ·  Mercedes Porosnicu, MD (1)  ·  Paul Germonpre, MD (1)  ·  Rita Axelrod, MD (1)  ·  Thomas E. Stinchcombe, MD (1)

Results publications

PMID 24013936, PMID 35379845

NIH funding

2005 (1), P30CA006973 (1), P30CA012197 (1), P30CA016672 (1), P30CA022453 (1), P30CA068485 (1), U10CA032102 (1), U10CA180888 (1)